Back
Blueprint Medicines Stock Price Chart
Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
50
BPMC
Blueprint Medicines
Last Price:
$128.43
Seasonality Move:
10.35%
7 Day Trial
ALL ACCESS PASS
$
7
How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128.17 | Buy |
| 20-day SMA: | 121.09 | Buy |
| 50-day SMA: | 104.25 | Buy |
| 200-day SMA: | 96.1 | Buy |
| 8-day EMA: | 127.55 | Buy |
| 20-day EMA: | 121.54 | Buy |
| 50-day EMA: | 110.11 | Buy |
| 200-day EMA: | 98.48 | Buy |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.37 | Buy |
| Relative Strength Index (14 RSI): | 75.84 | Buy |
| Chaikin Money Flow: | 2405267 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.82 - 130.54) | Buy |
| Bollinger Bands (100): | (84.96 - 114.18) | Buy |
Blueprint Medicines Technical Analysis
| Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 128.40 while BPMC 8-day simple moving average is 128.17, which is a Buy signal.
-
The stock price of BPMC is 128.40 while Blueprint Medicines 20-day SMA is 121.09, which makes it a Buy.
-
Blueprint Medicines 50-day simple moving average is 104.25 while BPMC share price is 128.40, making it a Buy technically.
-
BPMC stock price is 128.40 and Blueprint Medicines 200-day simple moving average is 96.10, creating a Buy signal.
BPMC Technical Analysis vs Fundamental Analysis
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a SellThe current Blueprint Medicines [BPMC] share price is $128.40. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Blueprint Medicines Stock Info
Market Cap:
8.3B
Price in USD:
128.40
Share Volume:
3.4M
Blueprint Medicines 52-Week Range
52-Week High:
128.45
52-Week Low:
73.04
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?The Blueprint Medicines stock price is 128.40 USD today.
-
Will BPMC stock go up or go down?Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators
-
Is Blueprint Medicines overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is overvalued.
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 128.40 while BPMC 8-day exponential moving average is 127.55, which is a Buy signal.
-
The stock price of BPMC is 128.40 while Blueprint Medicines 20-day EMA is 121.54, which makes it a Buy.
-
Blueprint Medicines 50-day exponential moving average is 110.11 while BPMC share price is 128.40, making it a Buy technically.
-
BPMC stock price is 128.40 and Blueprint Medicines 200-day simple moving average is 98.48, creating a Buy signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
-
BPMC Moving Average Covergence Divergence (MACD) indicator is 7.37, suggesting Blueprint Medicines is a Buy
-
Blueprint Medicines Relative Strength Index (RSI) is 75.84, which suggest Blueprint Medicines is overbought
-
The Bollinger Bands (25) for Blueprint Medicines is (103.82 - 130.54), which suggest Blueprint Medicines is a Buy
-
The Bollinger Bands (100) for Blueprint Medicines is (84.96 - 114.18), which suggest Blueprint Medicines is a Buy
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.